Alcohol Misuse, Gut Microbial Dysbiosis and PrEP Care Continuum: Application and Efficacy of SBIRT Intervention
Shirish S Barve · with National Institute on Alcohol Abuse and Alcoholism (NIAAA) · NCT06005298
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–85 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 120
- US sites recruiting
- 1
- Study start
- August 1, 2023
- Record last updated
- July 22, 2024
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This randomized control trial study among Pre-exposure prophylactic users (PrEP) aims to learn and determine the efficacy of Screening, brief intervention, and referral to treatment (SBRIT) in reducing the risk of alcohol use. The main questions it aims to answer are:
- How alcohol use impacts the PrEP continuum and to understand how early intervention and treatment approach affects alcohol use and PrEP adherence.
- Investigate the effectiveness of the SBIRT intervention in preventing hazardous alcohol use and its impact on gut dysbiosis in PrEP users.
- To determine alterations in the gut microbiome (dysbiosis), intestinal homeostasis, systemic inflammation, and markers of liver disease associated with hazardous alcohol use among PrEP users.
Being studied: Screening, Brief Intervention, Referral to Treatment (SBIRT)
Conditions: Alcohol Use Disorder; Risk Behavior, Health; Dysbiosis; HIV Infections
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age: 18-85 years
- Confirmation of seronegative HIV, Hep B, and Hep C status
- PrEP users
- English-speaking or Spanish speaking
- Cognitively competent to provide consent
- Attend a participating healthcare facility
Exclusion Criteria
- Inability to consent
- Existing diagnosis of major psychiatric illness
- Unstable medical conditions (e.g., cancer)
- Taking immunosuppressants or Chemotherapy
- Taking daily antibiotics or probiotics
- Severe gastrointestinal/liver disease
- Autoimmune disease
Recruiting US locations
University of Louisville
Louisville, KY 40202
Site contact: Andrea M Reyes Vega, MD,MSc · 502-852-8884 · a0reye02@louisville.edu
Study contacts (from the official record)
- Andrea Reyes Vega, MD, MSc · 502852884 · a0reye02@louisville.edu
- Vania Remenik, MD · 5028528884 · vania.remenik@louisville.edu
Similar studies in Kentucky
All healthy volunteers studies in Kentucky →- RecruitingHealthy volunteersPhase 1
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Merck Sharp & Dohme LLC
- Location
- Louisville, KY + 14 other US sites
- Eligibility basics
- Ages 2 mo–1
- RecruitingHealthy volunteersPhase 1/Phase 2
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Xencor, Inc.
- Location
- Louisville, KY + 27 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteersPhase 1/Phase 2
Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus
Gilead Sciences
- Location
- Louisville, KY + 4 other US sites
- Eligibility basics
- Ages 18–69
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Louisville, KY + 18 other US sites
- Eligibility basics
- Ages 18–100